Asia-Pacific Connected Handheld Devices Market
- Report Code: CO 1001
- Publish Date: Upcoming
Handheld mobile devices within healthcare delivery organization serve many purposes, such as results viewing, ordering, e-prescribing, charge capture, vital sign entry, dictation, reference data access, remote monitoring, and internet access. These organizations depend on speed, accuracy, and productivity to improve the response time and save lives. With devices such as PDAs, tablets and smart phones, a clinician no longer has to rely exclusively on a bedside terminal or a stationary workstation to retrieve patient health or medical information.
The Asian connected handheld devices market, mainly driven by the growing need for speed, accuracy, and productivity to improve response time, was valued at $0.93 billion in 2013 and is expected to reach $3.40 billion by 2018, at a CAGR of 29.2% from 2013 to 2018.
The report analyzes the market in terms of 5 products, such as Smartphone, tablet PC, mobile phone, PDA, and pager. The Smartphone segment accounted for the largest share in the overall Asian handheld device market, valued at $0.35 billion in 2013, and is expected to reach $1.40 billion by 2018, at a CAGR of 32% during the period under consideration. The tablet segment is projected to grow at the fastest CAGR of 33.6%, as compared to other handheld devices, owing to its user-friendliness.
China led the Asian connected handheld devices market with 42% share in 2013, and is expected to reach a value of $1.40 billion by 2018, at a CAGR of 28.6%, followed by Japan and India. India and China offer huge investment opportunities as these markets enter the growth stage of the industry life cycle.
The report also provides an extensive competitive landscaping of the leading companies operating in this market. The main companies that are extensively covered in this report are Vocera Communications, Siemens Healthcare, GE Healthcare, Verizon Communications Inc., Cisco Systems Inc., Alcatel–Lucent, Apple, AT&T, Motorola Solutions, and Samsung Group, among others.
Customization Options:
Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment levels
- Applications of the products (segment and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Brand/Product Perception Matrix
- A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North America Wireless Health North America Wireless health market, mainly driven by increasing awareness, aging population, need to combat increasing healthcare expenditure, chronic disease management, and technological advances in the field was pegged at $10.97 billion in 2013 and expected to be $26.97 billion by 2018, growing at a CAGR of 19.7%. |
Upcoming |
|
|
Europe Wireless Health The European Wireless health market, mainly driven by increasing awareness, aging population, need to combat increasing healthcare expenditure, chronic disease management, and technological advances in the field was pegged at $8.78 billion in 2013 and expected to be $20.96 billion by 2018, growing at a CAGR of 19.0%. |
Upcoming |
|
|
Asia Wireless Health Asia wireless health market, mainly driven by increasing awareness, aging population, need to combat increasing healthcare expenditure, chronic disease management, and technological advances in the field was pegged at $3.36 billion in 2013 and expected to be $10.56 billion by 2018, growing at a CAGR of 25.7%. |
Upcoming |
